%0 Journal Article %T Efficacy and safety of camrelizumab plus chemotherapy versus chemotherapy alone in patients with untreated, HER2-negative, unresectable locally advanced, or metastatic gastric cancer or gastroesophageal junction cancer: a retrospective comparative cohort study %A Xiang, Jinyu %A Gong, Wenjing %A Sun, Ping %A Wang, Xuan %A Liu, Aina %J Journal of Gastrointestinal Oncology %D 2022 %B 2022 %9 %! Efficacy and safety of camrelizumab plus chemotherapy versus chemotherapy alone in patients with untreated, HER2-negative, unresectable locally advanced, or metastatic gastric cancer or gastroesophageal junction cancer: a retrospective comparative cohort study %K %X %U https://jgo.amegroups.org/article/view/71084 %V 13 %N 6 %P 2874-2884 %@ 2219-679X